Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
NEW Guidance on the Presentation of Disease Burden in Advertising
-
Hello @manufacturer and @agency
PAAB is pleased to announce that we have broadened our approach to disease burden presentations within advertising. The new guidance can be found under the Resources tab on the PAAB website or by following this link to the Guidance on the Presentation of Disease Burden in Advertising.
PAAB will start accepting submissions under the new guidance as of February 19th, 2024 to allow a 6 week window for all organizations to familiarize themselves with this document prior to launch. You will also find a Case Examples document which has been designed to provide additional rationale and context for application.
Thank you to the 15+ agencies and manufacturers who provided feedback on the development of this revised approach.
PAAB would also like to thank bMod, CORE Health Communications, FCB Health Canada and GSW for their invaluable assistance in developing examples for this guidance.
